Profound Medical Corporation (TSX:PRN-V)
Analyst: David Kideckel, PhD, MBA
- Profound Medical Corp (TSX-V:PRN) - Q2/FY18 Full Commercialization on the Horizon for Game-Changing TULSA-PRO
- Profound Medical Corp (TSX-V:PRN) - Profound Top-line Data Reported in Prostate Cancer Pivotal Trial at the American Urological Association Annual Meeting in San Francisco
- Profound Medical Corp (TSX-V:PRN) - Full Commercial Potential is Looking Profoundly Positive, as Q1/FY18 are Reported
- Profound Medical Corp. (TSX-V:PRN) - A Profound Finish to 2017 with Profound Opportunities on the Horizon for 2018.
- Initiating Coverage: Profound Medical Corp (PRN-V) A Profound Innovation to Eradicate Prostate Cancer